Pulmonary Edema Therapeutics Market Analysis By Type(Cardiogenic pulmonary edema, Non-cardiogenic pulmonary edema), By Distribution Channel(Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) & Forecast 2024-2035

  • 02/03/2023
  • 245
  • Healthcare & Life Sciences
The global pulmonary edema therapeutics market size was valued at USD 150 million in 2021 and is projected to reach around USD 550 million in 2030 exhibiting a CAGR of 4.5% in the forecasted period. The rising incidence of heart failure, a major cause of pulmonary edema, an increasing geriatric population, and growing awareness about pulmonary edema are some of the key factors anticipated to drive the market. On the other hand, risks associated with heart treatments and side effects of the treatment are anticipated to hinder the growth of pulmonary edema therapeutics market growth.

The global market for pulmonary edema therapeutics will expand owing to the growing incidence of heart failure, a major cause of pulmonary edema. For example, as per the Places for Infectious prevention and Anticipation, in 2020, about 6.2 million grown-ups in the U.S. had a cardiovascular failure. Moreover, pulmonary edema is a disorder caused by extra fluids in the lungs. The fluids gather in the various air sacs in the lungs making it problematic to breathe. Furthermore, according to the National Heart, Lung and Blood Institute Atherosclerotic Risk in Communities (ARIC) study and Cardiovascular Health Study(CHS) there are around 1,260,000 new and recurrent coronary attacks per year- around 37% people experience coronary attack in a given year die from it. Additionally, the use of intra-ventricular septum contributing to the pumping function of left ventricle, lung parenchyma leading to lung diseases, upsurge in hypertensive crisis, pulmonary shunt and the use of arterial blood gas to measure the quantity of arterial gases such as oxygen and carbon dioxide is additionally driving its market growth.

The pulmonary edema therapeutics market and healthcare systems have been reasonably affected by the COVID-19 pandemic. Irregular alveolar fluid metabolism in the lungs, which causes fluid build-up in the alveolar airspace, is the major cause of COVID-19 mortality. Contamination with the severe acute respiratory syndrome coronavirus is the cause of this condition, which is called as pulmonary edema. Recognizing the pathways that may add to pulmonary edema in people with severe Coronavirus Disease (COVID-19) may help in the treatment of this situation.
Type Insights
Based on the type, the market is categorized into cardiogenic pulmonary edema and non-cardiogenic pulmonary edema. Out of these, cardiogenic pulmonary edema to hold an important share of the market in 2021. This is typically due to the growing rate of heart failure as it is one of the most common reasons of cardiogenic pulmonary edema and it is one of the most common grounds of death between adults worldwide.

Distribution Channel Insights
On the basis of distribution channel, the pulmonary edema therapeutics market has been categorized into retail pharmacies, hospital pharmacies, and online pharmacies. The hospital pharmacies category is to observe higher adoption of pulmonary edema therapeutics during the forecasted period. This is mostly owing to the accessibility of experienced healthcare professionals & the safety & efficiency throughout the treatment procedures also increasing hospital administration of pulmonary edema patients globally are the major aspects for the growth of the segment.

Region Insights
North America is projected to grow at a substantial CAGR during the forecasted period. The high prevalence of risk factors and the increasing acceptance of medications to treat pulmonary edema are factors for the growth of the market in the region. Additionally, the region's plenty of clinics and accessibility to scientifically advanced instruments are additionally driving the market's expansion. Moreover, the Centers for Disease Control and Prevention estimate that heart disease accounts for 647,000 annual deaths in the US, or 1 in 4 deaths.

Key Companies Insights
The market for Pulmonary edema therapeutics is moderately competitive. With the rising applications of Pulmonary edema therapeutics, new players are considering to enter the market. The companies are also involved in events like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the Pulmonary edema therapeutics market, ultimately boosting the market growth.

Some of the key companies working in the global Pulmonary edema therapeutics market include:
• AbbVie Inc.
• Apotex Inc.
• Bausch Health Companies Inc.
• CHIESI Farmaceutici SpA
• CMP Pharma Inc.
• Johnson and Johnson
• Lupin Ltd.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Validus Pharmaceuticals LLC
• Other players

Some of the Recent Developments:
• In February 2022, AstraZeneca is sticking out with an animated fantasyland theme for its Breztri TV ad but uses a blast from the past to demonstrate a brighter future. The primary phase requests patients to "Get Real" about their chronic obstructive pulmonary disease (COPD) and flare-ups, highlighting that improved breathing doesn't make everything "fun and nice."

• In January 2022, MediPines Corporation announced for complete national distribution throughout the United States for its exclusive AGM100device, first FDA-cleared, non-invasive pulmonary gas exchange analyzer system across the globe.

• In April 2020, Altimmune collaborated with University of Birmingham moving a single dose nasal vaccine AdCovid into clinical trials.

By Type
• Cardiogenic pulmonary edema
• Non-cardiogenic pulmonary edema
By Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
• Latin America
o Brazil
o Argentina
o Colombia
o South Africa
o Saudi Arabia
o Egypt
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.


Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI